ITGAX and dermatitis: CD11c-Tlr7Δ mice exhibited no improvement in any clinical disease parameters — including spleen and lymph node weight, proteinuria, dermatitis, glomerulonephritis, or interstitial nephritis — compared with Cre– controls (Figure 2, B and C).